Acelot
South San Francisco, California, United States · Biotechnology · 9 employees
Acelot is treating functional protein misfolding diseases where the appropriate therapeutic mechanism is a restoration of the normal protein homeostasis. Functional misfolded proteins are found in various diseases such as ALS, FTD, Parkinson’s, diabetes and cancer. Acelot’s platform combines generative AI, molecular dynamics simulations and proprietary assays to discover small molecules that resto
Funding history
- Venture - Series Unknown — $8.7M — Jul 2025
- Venture - Series Unknown — $6.5M — Apr 2025
- Seed — $8.7M — Nov 2024
Recent signals
- Jul 11, 2025: Raised $8.7M in Venture - Series Unknown
- Apr 24, 2025: Raised $6.5M in Venture - Series Unknown
- Nov 21, 2024: Raised $8.7M in Seed
See plans & pricing → Track Acelot’s funding, hiring, and signals — with verified contacts — on Fundz.